Logo

Sanofi-Aventis Expands Aureus Pharma Pact

Nov 05, 2009

NEW YORK (GenomeWeb News) – Sanofi-Aventis has extended a license agreement with Aureus Pharma for its data-management line, including its latest database tools, for three years, Aureus said today.

Paris-based Aureus said it will provide its new AurScope knowledge databases and will update its existing databases for the drug maker’s R&D programs.

The therapeutic targets in the databases include kinase inhibitors, nuclear receptors, GPCR protein receptors, and drug safety information related to absorption, distribution, metabolism, and excretion.

The new pact extends a relationship that has been ongoing for seven years, Aureus said.

Financial terms of the agreement were not released.

Filed under

Informatics
Sanofi
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.